policies >  DOI:10.25504/FAIRsharing.7KZpOx
FAIRsharing is in read-only mode until September while we migrate our data to our new, improved system. In the meantime, please read our blog post or get in touch with us if you need to edit or add records, or have any questions.

ready Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma)

General Information

Homepage https://druggablegenome.net/IDGPolicies#Policy7

Countries that developed this resource Denmark , United Kingdom , United States

Published in 2018

Type: Project


IDG members are encouraged to foster collaborations and interactions with individual laboratories/researchers, consortia, associations, pharma, and biotech, as well as other outside entities. The guidelines outlined here are to enhance these interactions for the benefit of sharing IDG outcomes.

Collections/recommendations derived from this policy:

Taxonomic range

Knowledge Domains

How to cite this record FAIRsharing.org: Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma); DOI: https://doi.org/10.25504/FAIRsharing.7KZpOx; Last edited: Dec. 19, 2019, 11:07 a.m.; Last accessed: Jul 27 2021 4:10 a.m.

This record is maintained by dvidovic  ORCID

Record added: Oct. 3, 2019, 4:10 p.m. Record updated: Nov. 4, 2019, 11:31 a.m. by The FAIRsharing Team.
Show edit history


Record Maintainer


  • NIH (Government body)


Policy External Cross References

TOP Level Data Transparency: Not available

TOP qualifying comments: Not available

Standards and Databases mentioned in this policy


No Databases Listed


No Standards Listed

Usage / Access

Conditions of Use


No support information provided.

Additional Information